ID   CDK9_HUMAN              Reviewed;         489 AA.
AC   P50750-2;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   21-JUN-2005, sequence version 3.
DT   12-OCT-2022, entry version 236.
DE   RecName: Full=Isoform 2 of Cyclin-dependent kinase 9;
DE            EC=2.7.11.22 {ECO:0000269|PubMed:12037670, ECO:0000269|PubMed:20980437};
DE            EC=2.7.11.23 {ECO:0000269|PubMed:21127351, ECO:0000269|PubMed:28426094};
DE   AltName: Full=C-2K;
DE   AltName: Full=Cell division cycle 2-like protein kinase 4;
DE   AltName: Full=Cell division protein kinase 9 {ECO:0000303|PubMed:10903437};
DE   AltName: Full=Serine/threonine-protein kinase PITALRE {ECO:0000303|PubMed:8170997};
DE   AltName: Full=Tat-associated kinase complex catalytic subunit;
GN   Name=CDK9 {ECO:0000303|PubMed:10903437, ECO:0000312|HGNC:HGNC:1780};
GN   Synonyms=CDC2L4, TAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8170997; DOI=10.1073/pnas.91.9.3834;
RA   Grana X., de Luca A., Sang N., Fu Y., Claudio P.P., Rosenblatt J.,
RA   Morgan D.O., Giordano A.;
RT   "PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the
RT   retinoblastoma protein in vitro.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:3834-3838(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ALA-231.
RX   PubMed=7695608; DOI=10.1006/bbrc.1995.1375;
RA   Best J.L., Presky D.H., Swerlick R.A., Burns D.K., Chu W.;
RT   "Cloning of a full-length cDNA sequence encoding a cdc2-related protein
RT   kinase from human endothelial cells.";
RL   Biochem. Biophys. Res. Commun. 208:562-568(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-231.
RX   PubMed=10903437; DOI=10.1016/s0378-1119(00)00215-8;
RA   Liu H., Rice A.P.;
RT   "Genomic organization and characterization of promoter function of the
RT   human CDK9 gene.";
RL   Gene 252:51-59(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   INTERACTION WITH HIV TAT.
RX   PubMed=9491887; DOI=10.1016/s0092-8674(00)80939-3;
RA   Wei P., Garber M.E., Fang S.-M., Fischer W.H., Jones K.A.;
RT   "A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat
RT   and mediates its high-affinity, loop-specific binding to TAR RNA.";
RL   Cell 92:451-462(1998).
RN   [9]
RP   FUNCTION.
RX   PubMed=9857195; DOI=10.1093/emboj/17.24.7395;
RA   Wada T., Takagi T., Yamaguchi Y., Watanabe D., Handa H.;
RT   "Evidence that P-TEFb alleviates the negative effect of DSIF on RNA
RT   polymerase II-dependent transcription in vitro.";
RL   EMBO J. 17:7395-7403(1998).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH CCNT1 AND CCNT2.
RX   PubMed=9499409; DOI=10.1101/gad.12.5.755;
RA   Peng J.-M., Zhu Y., Milton J.T., Price D.H.;
RT   "Identification of multiple cyclin subunits of human P-TEFb.";
RL   Genes Dev. 12:755-762(1998).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; RNA POL II;
RP   SUPT5H AND NCL.
RX   PubMed=10393184; DOI=10.1093/emboj/18.13.3688;
RA   Parada C.A., Roeder R.G.;
RT   "A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-
RT   1 transcription.";
RL   EMBO J. 18:3688-3701(1999).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH CCNK.
RX   PubMed=10574912; DOI=10.1074/jbc.274.49.34527;
RA   Fu T.J., Peng J., Lee G., Price D.H., Flores O.;
RT   "Cyclin K functions as a CDK9 regulatory subunit and participates in RNA
RT   polymerase II transcription.";
RL   J. Biol. Chem. 274:34527-34530(1999).
RN   [13]
RP   FUNCTION.
RX   PubMed=10912001; DOI=10.1016/s1097-2765(00)80272-5;
RA   Wada T., Orphanides G., Hasegawa J., Kim D.-K., Shima D., Yamaguchi Y.,
RA   Fukuda A., Hisatake K., Oh S., Reinberg D., Handa H.;
RT   "FACT relieves DSIF/NELF-mediated inhibition of transcriptional elongation
RT   and reveals functional differences between P-TEFb and TFIIH.";
RL   Mol. Cell 5:1067-1072(2000).
RN   [14]
RP   FUNCTION.
RX   PubMed=10757782; DOI=10.1128/mcb.20.9.2970-2983.2000;
RA   Ivanov D., Kwak Y.T., Guo J., Gaynor R.B.;
RT   "Domains in the SPT5 protein that modulate its transcriptional regulatory
RT   properties.";
RL   Mol. Cell. Biol. 20:2970-2983(2000).
RN   [15]
RP   PHOSPHORYLATION BY PKA, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT SER-347;
RP   THR-350; SER-353; THR-354 AND SER-357, INTERACTION WITH HIV TAT, AND
RP   MUTAGENESIS OF 347-SER--SER-357 AND ASP-167.
RX   PubMed=10958691; DOI=10.1128/mcb.20.18.6958-6969.2000;
RA   Garber M.E., Mayall T.P., Suess E.M., Meisenhelder J., Thompson N.E.,
RA   Jones K.A.;
RT   "CDK9 autophosphorylation regulates high-affinity binding of the human
RT   immunodeficiency virus type 1 tat-P-TEFb complex to TAR RNA.";
RL   Mol. Cell. Biol. 20:6958-6969(2000).
RN   [16]
RP   FUNCTION, AND MUTAGENESIS OF ASP-167 AND THR-186.
RX   PubMed=11145967; DOI=10.1074/jbc.m010908200;
RA   Kim J.B., Sharp P.A.;
RT   "Positive transcription elongation factor B phosphorylates hSPT5 and RNA
RT   polymerase II carboxyl-terminal domain independently of cyclin-dependent
RT   kinase-activating kinase.";
RL   J. Biol. Chem. 276:12317-12323(2001).
RN   [17]
RP   FUNCTION.
RX   PubMed=11112772; DOI=10.1074/jbc.m006130200;
RA   Ping Y.-H., Rana T.M.;
RT   "DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1
RT   Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and
RT   DSIF during transcription elongation.";
RL   J. Biol. Chem. 276:12951-12958(2001).
RN   [18]
RP   FUNCTION.
RX   PubMed=11575923; DOI=10.1006/jmbi.2001.4991;
RA   Lavoie S.B., Albert A.L., Handa H., Vincent M., Bensaude O.;
RT   "The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by
RT   Cdk9.";
RL   J. Mol. Biol. 312:675-685(2001).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH CCNK/CYCLIN K.
RX   PubMed=11884399; DOI=10.1074/jbc.m200117200;
RA   Lin X., Taube R., Fujinaga K., Peterlin B.M.;
RT   "P-TEFb containing cyclin K and Cdk9 can activate transcription via RNA.";
RL   J. Biol. Chem. 277:16873-16878(2002).
RN   [20]
RP   INTERACTION WITH AFF4.
RX   PubMed=12065898; DOI=10.1007/bf02256070;
RA   Estable M.C., Naghavi M.H., Kato H., Xiao H., Qin J., Vahlne A.,
RA   Roeder R.G.;
RT   "MCEF, the newest member of the AF4 family of transcription factors
RT   involved in leukemia, is a positive transcription elongation factor-b-
RT   associated protein.";
RL   J. Biomed. Sci. 9:234-245(2002).
RN   [21]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12115727; DOI=10.1002/jcp.10130;
RA   Napolitano G., Licciardo P., Carbone R., Majello B., Lania L.;
RT   "CDK9 has the intrinsic property to shuttle between nucleus and cytoplasm,
RT   and enhanced expression of cyclin T1 promotes its nuclear localization.";
RL   J. Cell. Physiol. 192:209-215(2002).
RN   [22]
RP   FUNCTION.
RX   PubMed=11809800; DOI=10.1128/mcb.22.4.1079-1093.2002;
RA   Bourgeois C.F., Kim Y.K., Churcher M.J., West M.J., Karn J.;
RT   "Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing
RT   premature RNA release at terminator sequences.";
RL   Mol. Cell. Biol. 22:1079-1093(2002).
RN   [23]
RP   FUNCTION AS MYOD1 KINASE, CATALYTIC ACTIVITY, AND INTERACTION WITH MYOD1
RP   AND CCNT2.
RX   PubMed=12037670; DOI=10.1038/sj.onc.1205493;
RA   Simone C., Stiegler P., Bagella L., Pucci B., Bellan C., De Falco G.,
RA   De Luca A., Guanti G., Puri P.L., Giordano A.;
RT   "Activation of MyoD-dependent transcription by cdk9/cyclin T2.";
RL   Oncogene 21:4137-4148(2002).
RN   [24]
RP   INTERACTION WITH SUPT5H.
RX   PubMed=12718890; DOI=10.1016/s1097-2765(03)00101-1;
RA   Kwak Y.T., Guo J., Prajapati S., Park K.-J., Surabhi R.M., Miller B.,
RA   Gehrig P., Gaynor R.B.;
RT   "Methylation of SPT5 regulates its interaction with RNA polymerase II and
RT   transcriptional elongation properties.";
RL   Mol. Cell 11:1055-1066(2003).
RN   [25]
RP   FUNCTION.
RX   PubMed=15564463; DOI=10.1128/jvi.78.24.13522-13533.2004;
RA   Zhou M., Deng L., Lacoste V., Park H.U., Pumfery A., Kashanchi F.,
RA   Brady J.N., Kumar A.;
RT   "Coordination of transcription factor phosphorylation and histone
RT   methylation by the P-TEFb kinase during human immunodeficiency virus type 1
RT   transcription.";
RL   J. Virol. 78:13522-13533(2004).
RN   [26]
RP   FUNCTION.
RX   PubMed=14701750; DOI=10.1128/mcb.24.2.787-795.2004;
RA   Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B.M.;
RT   "Dynamics of human immunodeficiency virus transcription: P-TEFb
RT   phosphorylates RD and dissociates negative effectors from the
RT   transactivation response element.";
RL   Mol. Cell. Biol. 24:787-795(2004).
RN   [27]
RP   IDENTIFICATION IN INACTIVE 7SK SNRNP COMPLEX, AND PHOSPHORYLATION AT
RP   THR-186.
RX   PubMed=15965233; DOI=10.1074/jbc.m502712200;
RA   Li Q., Price J.P., Byers S.A., Cheng D., Peng J., Price D.H.;
RT   "Analysis of the large inactive P-TEFb complex indicates that it contains
RT   one 7SK molecule, a dimer of HEXIM1 or HEXIM2, and two P-TEFb molecules
RT   containing Cdk9 phosphorylated at threonine 186.";
RL   J. Biol. Chem. 280:28819-28826(2005).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH BRD4.
RX   PubMed=16109376; DOI=10.1016/j.molcel.2005.06.027;
RA   Jang M.K., Mochizuki K., Zhou M., Jeong H.S., Brady J.N., Ozato K.;
RT   "The bromodomain protein Brd4 is a positive regulatory component of P-TEFb
RT   and stimulates RNA polymerase II-dependent transcription.";
RL   Mol. Cell 19:523-534(2005).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH BRD4.
RX   PubMed=16109377; DOI=10.1016/j.molcel.2005.06.029;
RA   Yang Z., Yik J.H., Chen R., He N., Jang M.K., Ozato K., Zhou Q.;
RT   "Recruitment of P-TEFb for stimulation of transcriptional elongation by the
RT   bromodomain protein Brd4.";
RL   Mol. Cell 19:535-545(2005).
RN   [30]
RP   FUNCTION IN CYTOKINE SIGNALING, AND INTERACTION WITH STAT3.
RX   PubMed=17956865; DOI=10.1074/jbc.m706458200;
RA   Hou T., Ray S., Brasier A.R.;
RT   "The functional role of an interleukin 6-inducible CDK9.STAT3 complex in
RT   human gamma-fibrinogen gene expression.";
RL   J. Biol. Chem. 282:37091-37102(2007).
RN   [31]
RP   IDENTIFICATION IN THE 7SK SNRNP COMPLEX.
RX   PubMed=17643375; DOI=10.1016/j.molcel.2007.06.027;
RA   Jeronimo C., Forget D., Bouchard A., Li Q., Chua G., Poitras C.,
RA   Therien C., Bergeron D., Bourassa S., Greenblatt J., Chabot B.,
RA   Poirier G.G., Hughes T.R., Blanchette M., Price D.H., Coulombe B.;
RT   "Systematic analysis of the protein interaction network for the human
RT   transcription machinery reveals the identity of the 7SK capping enzyme.";
RL   Mol. Cell 27:262-274(2007).
RN   [32]
RP   ACETYLATION AT LYS-44, IDENTIFICATION IN COMPLEX WITH NCOR1; HEXIM1 AND
RP   HDAC3, AND MUTAGENESIS OF LYS-44.
RX   PubMed=17452463; DOI=10.1128/mcb.00857-06;
RA   Fu J., Yoon H.-G., Qin J., Wong J.;
RT   "Regulation of P-TEFb elongation complex activity by CDK9 acetylation.";
RL   Mol. Cell. Biol. 27:4641-4651(2007).
RN   [33]
RP   PHOSPHORYLATION AT THR-186, DEPHOSPHORYLATION BY PPP1CA, P-TEFB/7SK SNRNP
RP   COMPLEX, SUBUNIT, INTERACTION WITH BRD4, AND ACTIVITY REGULATION.
RX   PubMed=18483222; DOI=10.1101/gad.1636008;
RA   Chen R., Liu M., Li H., Xue Y., Ramey W.N., He N., Ai N., Luo H., Zhu Y.,
RA   Zhou N., Zhou Q.;
RT   "PP2B and PP1alpha cooperatively disrupt 7SK snRNP to release P-TEFb for
RT   transcription in response to Ca2+ signaling.";
RL   Genes Dev. 22:1356-1368(2008).
RN   [34]
RP   PHOSPHORYLATION AT THR-186, AND DEPHOSPHORYLATION BY PPM1A AND PPM1B.
RX   PubMed=18829461; DOI=10.1074/jbc.m807495200;
RA   Wang Y., Dow E.C., Liang Y.Y., Ramakrishnan R., Liu H., Sung T.L., Lin X.,
RA   Rice A.P.;
RT   "Phosphatase PPM1A regulates phosphorylation of Thr-186 in the Cdk9 T-
RT   loop.";
RL   J. Biol. Chem. 283:33578-33584(2008).
RN   [35]
RP   IDENTIFICATION IN COMPLEX WITH LARP7 IN 7SK SNRNP COMPLEX.
RX   PubMed=18249148; DOI=10.1016/j.molcel.2008.01.003;
RA   He N., Jahchan N.S., Hong E., Li Q., Bayfield M.A., Maraia R.J., Luo K.,
RA   Zhou Q.;
RT   "A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-
RT   dependent transcriptional elongation and tumorigenesis.";
RL   Mol. Cell 29:588-599(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-35 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [37]
RP   ACETYLATION AT LYS-44 AND LYS-48 BY PCAF/KAT2B AND GCN5/KAT2A, ACTIVITY
RP   REGULATION BY ACETYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=18250157; DOI=10.1128/mcb.01557-07;
RA   Sabo A., Lusic M., Cereseto A., Giacca M.;
RT   "Acetylation of conserved lysines in the catalytic core of cyclin-dependent
RT   kinase 9 inhibits kinase activity and regulates transcription.";
RL   Mol. Cell. Biol. 28:2201-2212(2008).
RN   [38]
RP   FUNCTION IN CYTOKINE SIGNALING, AND INTERACTION WITH RELA/P65.
RX   PubMed=18362169; DOI=10.1128/mcb.01152-07;
RA   Nowak D.E., Tian B., Jamaluddin M., Boldogh I., Vergara L.A., Choudhary S.,
RA   Brasier A.R.;
RT   "RelA Ser276 phosphorylation is required for activation of a subset of NF-
RT   kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1
RT   complexes.";
RL   Mol. Cell. Biol. 28:3623-3638(2008).
RN   [39]
RP   FUNCTION IN HISTONE REGULATION.
RX   PubMed=19844166; DOI=10.4161/cc.8.22.9890;
RA   Pirngruber J., Shchebet A., Johnsen S.A.;
RT   "Insights into the function of the human P-TEFb component CDK9 in the
RT   regulation of chromatin modifications and co-transcriptional mRNA
RT   processing.";
RL   Cell Cycle 8:3636-3642(2009).
RN   [40]
RP   FUNCTION IN HISTONE H2B UBIQUITINATION.
RX   PubMed=19575011; DOI=10.1038/embor.2009.108;
RA   Pirngruber J., Shchebet A., Schreiber L., Shema E., Minsky N.,
RA   Chapman R.D., Eick D., Aylon Y., Oren M., Johnsen S.A.;
RT   "CDK9 directs H2B monoubiquitination and controls replication-dependent
RT   histone mRNA 3'-end processing.";
RL   EMBO Rep. 10:894-900(2009).
RN   [41]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347 AND THR-350,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [42]
RP   FUNCTION IN DNA REPAIR, AND INTERACTION WITH KU70/XRCC6.
RX   PubMed=20493174; DOI=10.1016/j.bbrc.2010.05.092;
RA   Liu H., Herrmann C.H., Chiang K., Sung T.L., Moon S.H., Donehower L.A.,
RA   Rice A.P.;
RT   "55K isoform of CDK9 associates with Ku70 and is involved in DNA repair.";
RL   Biochem. Biophys. Res. Commun. 397:245-250(2010).
RN   [43]
RP   FUNCTION IN CDK9/CYCLIN K COMPLEX DURING REPLICATION STRESS.
RX   PubMed=20930849; DOI=10.1038/embor.2010.153;
RA   Yu D.S., Zhao R., Hsu E.L., Cayer J., Ye F., Guo Y., Shyr Y., Cortez D.;
RT   "Cyclin-dependent kinase 9-cyclin K functions in the replication stress
RT   response.";
RL   EMBO Rep. 11:876-882(2010).
RN   [44]
RP   FUNCTION IN CARDIAC HYPERTROPHY, AND IDENTIFICATION IN COMPLEX WITH
RP   CCNT1/CYCLIN-T1; EP300 AND GATA4.
RX   PubMed=20081228; DOI=10.1074/jbc.m109.070458;
RA   Sunagawa Y., Morimoto T., Takaya T., Kaichi S., Wada H., Kawamura T.,
RA   Fujita M., Shimatsu A., Kita T., Hasegawa K.;
RT   "Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex
RT   required for phenylephrine-induced hypertrophy in cardiomyocytes.";
RL   J. Biol. Chem. 285:9556-9568(2010).
RN   [45]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors into
RT   a bifunctional complex for coordinated activation of HIV-1 transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [46]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L.,
RA   Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [47]
RP   FUNCTION IN AR KINASE, CATALYTIC ACTIVITY, AND INTERACTION WITH AR.
RX   PubMed=20980437; DOI=10.1210/me.2010-0238;
RA   Gordon V., Bhadel S., Wunderlich W., Zhang J., Ficarro S.B., Mollah S.A.,
RA   Shabanowitz J., Hunt D.F., Xenarios I., Hahn W.C., Conaway M., Carey M.F.,
RA   Gioeli D.;
RT   "CDK9 regulates AR promoter selectivity and cell growth through serine 81
RT   phosphorylation.";
RL   Mol. Endocrinol. 24:2267-2280(2010).
RN   [48]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [49]
RP   IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [50]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-186, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [51]
RP   ACTIVITY REGULATION BY CDKI-71.
RX   PubMed=21484792; DOI=10.1002/ijc.26127;
RA   Liu X., Shi S., Lam F., Pepper C., Fischer P.M., Wang S.;
RT   "CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer
RT   cells compared to flavopiridol.";
RL   Int. J. Cancer 130:1216-1226(2012).
RN   [52]
RP   FUNCTION AS RPB1/POLR2A CTD KINASE, CATALYTIC ACTIVITY, POLYUBIQUITINATION
RP   BY UBR5, AND INTERACTION WITH UBR5 AND TFIIS/TCEA1.
RX   PubMed=21127351; DOI=10.1074/jbc.m110.176628;
RA   Cojocaru M., Bouchard A., Cloutier P., Cooper J.J., Varzavand K.,
RA   Price D.H., Coulombe B.;
RT   "Transcription factor IIS cooperates with the E3 ligase UBR5 to
RT   ubiquitinate the CDK9 subunit of the positive transcription elongation
RT   factor B.";
RL   J. Biol. Chem. 286:5012-5022(2011).
RN   [53]
RP   PHOSPHORYLATION AT THR-186, ACTIVITY REGULATION, DEGRADATION BY THE
RP   PROTEASOME, AND MUTAGENESIS OF THR-186.
RX   PubMed=21448926; DOI=10.1002/jcp.22760;
RA   Ramakrishnan R., Rice A.P.;
RT   "Cdk9 T-loop phosphorylation is regulated by the calcium signaling
RT   pathway.";
RL   J. Cell. Physiol. 227:609-617(2012).
RN   [54]
RP   PHOSPHORYLATION AT SER-175, DEPHOSPHORYLATION AT SER-175 BY PP1, AND
RP   MUTAGENESIS OF SER-175.
RX   PubMed=21533037; DOI=10.1371/journal.pone.0018985;
RA   Ammosova T., Obukhov Y., Kotelkin A., Breuer D., Beullens M., Gordeuk V.R.,
RA   Bollen M., Nekhai S.;
RT   "Protein phosphatase-1 activates CDK9 by dephosphorylating Ser175.";
RL   PLoS ONE 6:E18985-E18985(2011).
RN   [55]
RP   REVIEW ON NELF AND DSIF KINASE ACTIVITY.
RX   PubMed=16885020; DOI=10.1016/j.molcel.2006.06.014;
RA   Peterlin B.M., Price D.H.;
RT   "Controlling the elongation phase of transcription with P-TEFb.";
RL   Mol. Cell 23:297-305(2006).
RN   [56]
RP   REVIEW ON CYTOKINE SIGNALING.
RX   PubMed=18728388; DOI=10.4161/cc.7.17.6594;
RA   Brasier A.R.;
RT   "Expanding role of cyclin dependent kinases in cytokine inducible gene
RT   expression.";
RL   Cell Cycle 7:2661-2666(2008).
RN   [57]
RP   REVIEW ON TRANSCRIPTION REGULATION, AND INHIBITORS.
RX   PubMed=19029809; DOI=10.4161/cc.7.23.7122;
RA   Romano G., Giordano A.;
RT   "Role of the cyclin-dependent kinase 9-related pathway in mammalian gene
RT   expression and human diseases.";
RL   Cell Cycle 7:3664-3668(2008).
RN   [58]
RP   REVIEW ON TRANSCRIPTION REGULATION, AND INHIBITORS.
RX   PubMed=18423896; DOI=10.1016/j.tips.2008.03.003;
RA   Wang S., Fischer P.M.;
RT   "Cyclin-dependent kinase 9: a key transcriptional regulator and potential
RT   drug target in oncology, virology and cardiology.";
RL   Trends Pharmacol. Sci. 29:302-313(2008).
RN   [59]
RP   ACTIVITY REGULATION, AND GENE FAMILY.
RX   PubMed=19238148; DOI=10.1038/nrc2602;
RA   Malumbres M., Barbacid M.;
RT   "Cell cycle, CDKs and cancer: a changing paradigm.";
RL   Nat. Rev. Cancer 9:153-166(2009).
RN   [60]
RP   REVIEW ON CARDIAC HYPERTROPHY, AND INHIBITORS.
RX   PubMed=19757441; DOI=10.1002/med.20172;
RA   Krystof V., Chamrad I., Jorda R., Kohoutek J.;
RT   "Pharmacological targeting of CDK9 in cardiac hypertrophy.";
RL   Med. Res. Rev. 30:646-666(2010).
RN   [61]
RP   REVIEW ON GENOME INTEGRITY MAINTENANCE.
RX   PubMed=21200140; DOI=10.4161/cc.10.1.14364;
RA   Yu D.S., Cortez D.;
RT   "A role for cdk9-cyclin k in maintaining genome integrity.";
RL   Cell Cycle 10:28-32(2011).
RN   [62]
RP   INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL
RP   INFECTION).
RX   PubMed=23029222; DOI=10.1371/journal.pone.0045749;
RA   Guo L., Wu W.J., Liu L.D., Wang L.C., Zhang Y., Wu L.Q., Guan Y., Li Q.H.;
RT   "Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene
RT   promoters by binding to and blocking the recruitment of P-TEFb.";
RL   PLoS ONE 7:E45749-E45749(2012).
RN   [63]
RP   INTERACTION WITH BRD4 AND JMJD6.
RX   PubMed=24360279; DOI=10.1016/j.cell.2013.10.056;
RA   Liu W., Ma Q., Wong K., Li W., Ohgi K., Zhang J., Aggarwal A.,
RA   Rosenfeld M.G.;
RT   "Brd4 and JMJD6-associated anti-pause enhancers in regulation of
RT   transcriptional pause release.";
RL   Cell 155:1581-1595(2013).
RN   [64]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-347, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT THR-54 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [65]
RP   INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL
RP   INFECTION).
RX   PubMed=25233083; DOI=10.1371/journal.pone.0107654;
RA   Zaborowska J., Baumli S., Laitem C., O'Reilly D., Thomas P.H., O'Hare P.,
RA   Murphy S.;
RT   "Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with
RT   cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription
RT   elongation.";
RL   PLoS ONE 9:e107654-e107654(2014).
RN   [66]
RP   INTERACTION WITH HSF1.
RX   PubMed=27189267; DOI=10.1038/srep26294;
RA   Pan X.Y., Zhao W., Zeng X.Y., Lin J., Li M.M., Shen X.T., Liu S.W.;
RT   "Heat shock factor 1 mediates latent HIV reactivation.";
RL   Sci. Rep. 6:26294-26294(2016).
RN   [67]
RP   FUNCTION, CATALYTIC ACTIVITY, ACETYLATION AT LYS-48, DEACETYLATION BY
RP   SIRT7, AND MUTAGENESIS OF LYS-48.
RX   PubMed=28426094; DOI=10.1093/nar/gkx053;
RA   Blank M.F., Chen S., Poetz F., Schnoelzer M., Voit R., Grummt I.;
RT   "SIRT7-dependent deacetylation of CDK9 activates RNA polymerase II
RT   transcription.";
RL   Nucleic Acids Res. 45:2675-2686(2017).
RN   [68]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29335245; DOI=10.15252/embr.201744311;
RA   Brauns-Schubert P., Schubert F., Wissler M., Weiss M., Schlicher L.,
RA   Bessler S., Safavi M., Miething C., Borner C., Brummer T., Maurer U.;
RT   "CDK9-mediated phosphorylation controls the interaction of TIP60 with the
RT   transcriptional machinery.";
RL   EMBO Rep. 19:244-256(2018).
RN   [69]
RP   INTERACTION WITH HHV-1 TRANSCRIPTIONAL REGULATOR ICP22 (MICROBIAL
RP   INFECTION).
RX   PubMed=34696162; DOI=10.3390/vaccines9101054;
RA   Isa N.F., Bensaude O., Aziz N.C., Murphy S.;
RT   "HSV-1 ICP22 Is a Selective Viral Repressor of Cellular RNA Polymerase II-
RT   Mediated Transcription Elongation.";
RL   Vaccines (Basel) 9:0-0(2021).
RN   [70]
RP   X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF 1-345 IN COMPLEX WITH HIV-1 TAT
RP   AND CCNT1, AND PHOSPHORYLATION AT THR-186.
RX   PubMed=20535204; DOI=10.1038/nature09131;
RA   Tahirov T.H., Babayeva N.D., Varzavand K., Cooper J.J., Sedore S.C.,
RA   Price D.H.;
RT   "Crystal structure of HIV-1 Tat complexed with human P-TEFb.";
RL   Nature 465:747-751(2010).
RN   [71]
RP   X-RAY CRYSTALLOGRAPHY (2.48 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR
RP   FLAVOPIRIDOL; ATP AND CCNT1, PHOSPHORYLATION AT THR-186 SER-347; THR-362
RP   AND THR-363, AUTOPHOSPHORYLATION, AND MUTAGENESIS OF THR-186.
RX   PubMed=18566585; DOI=10.1038/emboj.2008.121;
RA   Baumli S., Lolli G., Lowe E.D., Troiani S., Rusconi L., Bullock A.N.,
RA   Debreczeni J.E., Knapp S., Johnson L.N.;
RT   "The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol
RT   and regulation by phosphorylation.";
RL   EMBO J. 27:1907-1918(2008).
RN   [72]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 2-330 IN COMPLEX WITH INHIBITOR
RP   DRB, AND PHOSPHORYLATION AT THR-186.
RX   PubMed=20851342; DOI=10.1016/j.chembiol.2010.07.012;
RA   Baumli S., Endicott J.A., Johnson L.N.;
RT   "Halogen bonds form the basis for selective P-TEFb inhibition by DRB.";
RL   Chem. Biol. 17:931-936(2010).
RN   [73]
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 2-330 IN COMPLEX WITH CCNT1;
RP   INHIBITORS ROSCOVITINE AND CR8, PHOSPHORYLATION AT THR-186, AND ACTIVITY
RP   REGULATION.
RX   PubMed=21779453; DOI=10.1177/1947601910369817;
RA   Bettayeb K., Baunbaek D., Delehouze C., Loaec N., Hole A.J., Baumli S.,
RA   Endicott J.A., Douc-Rasy S., Benard J., Oumata N., Galons H., Meijer L.;
RT   "CDK inhibitors roscovitine and CR8 trigger Mcl-1 down-regulation and
RT   apoptotic cell death in neuroblastoma cells.";
RL   Genes Cancer 1:369-380(2010).
RN   [74]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-59.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [75]
RP   VARIANT CYS-225.
RX   PubMed=30237576; DOI=10.1038/s41436-018-0138-x;
RA   Maddirevula S., Alzahrani F., Al-Owain M., Al Muhaizea M.A., Kayyali H.R.,
RA   AlHashem A., Rahbeeni Z., Al-Otaibi M., Alzaidan H.I., Balobaid A.,
RA   El Khashab H.Y., Bubshait D.K., Faden M., Yamani S.A., Dabbagh O.,
RA   Al-Mureikhi M., Jasser A.A., Alsaif H.S., Alluhaydan I., Seidahmed M.Z.,
RA   Alabbasi B.H., Almogarri I., Kurdi W., Akleh H., Qari A., Al Tala S.M.,
RA   Alhomaidi S., Kentab A.Y., Salih M.A., Chedrawi A., Alameer S., Tabarki B.,
RA   Shamseldin H.E., Patel N., Ibrahim N., Abdulwahab F., Samira M., Goljan E.,
RA   Abouelhoda M., Meyer B.F., Hashem M., Shaheen R., AlShahwan S.,
RA   Alfadhel M., Ben-Omran T., Al-Qattan M.M., Monies D., Alkuraya F.S.;
RT   "Autozygome and high throughput confirmation of disease genes candidacy.";
RL   Genet. Med. 21:736-742(2019).
CC   -!- INTERACTION:
CC       P50750-2; P28799: GRN; NbExp=3; IntAct=EBI-12029902, EBI-747754;
CC       P50750-2; P28799-2: GRN; NbExp=3; IntAct=EBI-12029902, EBI-25860013;
CC       P50750-2; Q6XYB7-2: LBX2; NbExp=3; IntAct=EBI-12029902, EBI-12029900;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P50750-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P50750-2; Sequence=VSP_016288;
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   ProteomicsDB; 56264; -.
DR   Proteomes; UP000005640; Chromosome 9.
PE   1: Evidence at protein level;
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195"
FT   MOD_RES         54
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
SQ   SEQUENCE   489 AA;  53365 MW;  A0437DC909235A20 CRC64;
     MQRDAPPRAP APAPRLPAPP IGAAASSGGG GGGGSGGGGG GASAAPAPPG LSGTTSPRGP
     GGGRRAEEAG SAPRGRKWPW RRKWRGRGGA WSAAAAGPGA GAAAAATGGG GGALEAAMAK
     QYDSVECPFC DEVSKYEKLA KIGQGTFGEV FKARHRKTGQ KVALKKVLME NEKEGFPITA
     LREIKILQLL KHENVVNLIE ICRTKASPYN RCKGSIYLVF DFCEHDLAGL LSNVLVKFTL
     SEIKRVMQML LNGLYYIHRN KILHRDMKAA NVLITRDGVL KLADFGLARA FSLAKNSQPN
     RYTNRVVTLW YRPPELLLGE RDYGPPIDLW GAGCIMAEMW TRSPIMQGNT EQHQLALISQ
     LCGSITPEVW PNVDNYELYE KLELVKGQKR KVKDRLKAYV RDPYALDLID KLLVLDPAQR
     IDSDDALNHD FFWSDPMPSD LKGMLSTHLT SMFEYLAPPR RKGSQITQQS TNQSRNPATT
     NQTEFERVF
//
